Functional characterization of the cAMP-binding proteins Epac in cardiac myocytes

Pharmacological Reports

Volumn 61, Issue 1, 2009, Pages 146-153

  Métrich, Mélanie ^a,b   Morel, Eric ^a,b   Berthouze, Magali ^a,b   Pereira, Laetitia ^d,e   Charron, Philippe ^c   Gomez, Ana Maria ^d,e   Lezoualc'h, Frank ^a,b  

^a Universite Paris Sud   (France)

^b IPSIT   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d INSERM   (France)

^e UNIV MONTPELLIER   (France)

Author keywords

Calcium; CAMP; Cardiac hypertrophy; G protein coupled receptor; Guanine nucleotide exchange factor; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CYCLIC AMP; CYCLIC AMP BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; EXCHANGE FACTOR DIRECTLY ACTIVATED BY CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE 7; PHOSPHODIESTERASE; PHOSPHOLIPASE C; RAC PROTEIN; RAP1 PROTEIN; RAS PROTEIN; SODIUM CALCIUM EXCHANGE PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

CALCIUM TRANSPORT; CELL GROWTH; CONFERENCE PAPER; ENZYME ACTIVITY; EXCITATION CONTRACTION COUPLING; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 66949178986     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70017-9     Document Type: Conference Paper

References (59)

1. Beavo JA, Brunton LL: Cyclic nucleotide research - still expanding after half a century. Nat Rev Mol Cell Biol, 2002, 3, 710-718.
2. Berenji K, Drazner MH, Rothermel BA, Hill JA: Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol, 2005, 289, H8-H16.
3. Bers DM: Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol, 2008, 70, 23-49.
4. Bers DM, Ziolo MT: When is cAMP not cAMP? Effects of compartmentalization. Circ Res, 2001, 89, 373-375.
5. Borland G, Gupta M, Magiera MM, Rundell CJ, Fuld S, Yarwood SJ: Microtubule-associated protein 1B-light chain 1 enhances activation of Rap1 by exchange protein activated by cyclic AMP but not intracellular targeting. Mol Pharmacol, 2006, 69, 374-384.
6. Bos JL: Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci, 2006, 31, 680-686.
7. Cheng X, Ji Z, Tsalkova T, Mei F: Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim Biophys Sin (Shanghai), 2008, 40, 651-662.
8. Curran J, Hinton MJ, Rios E, Bers DM, Shannon TR: Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ Res, 2007, 100, 391-398.
9. Dao KK, Teigen K, Kopperud R, Hodneland E, Schwede F, Christensen AE, Martinez A, Doskeland SO: Epac1 and cAMP-dependent protein kinase holoenzyme have similar cAMP affinity, but their cAMP domains have distinct structural features and cyclic nucleotide recognition. J Biol Chem, 2006, 281, 21500-21511.
10. de Rooij J, Rehmann H, van Triest M, Cool RH, Witting-hofer A, Bos JL: Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem, 2000, 275, 20829-20836.
11. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL: Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature, 1998, 396, 474-477.
12. Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, Kapiloff MS, Scott JD: The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature, 2005, 437, 574-578.
13. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Doskeland SO et al.: A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol, 2002, 4, 901-906.
14. 3 muscarinic acetylcholine receptor mediated by cyclic AMP and the GTPase Rap2B. J Biol Chem, 2002, 277, 16805-16813.
15. Feng Y, Dai DZ, Na T, Cui B, Wang T, Zhang Y, Dai Y: Endothelin receptor antagonist CPU0213 suppresses ventricular fibrillation in L-thyroxin induced cardiomyopathy. Pharmacol Rep, 2007, 59, 306-314.
16. Fischmeister R, Castro LR, Abi-Gerges A, Rochais F, Jurevicius J, Leroy J, Vandecasteele G: Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res, 2006, 99, 816-828.
17. Frey N, Katus HA, Olson EN, Hill JA: Hypertrophy of the heart: a new therapeutic target? Circulation, 2004, 109, 1580-1589.
18. George CH, Jundi H, Thomas NL, Fry DL, Lai FA: Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies. J Mol Cell Cardiol, 2007, 42, 34-50.
19. Hancock JF: Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol, 2003, 4, 373-384.
20. Ho KK, Pinsky JL, Kannel WB, Levy D: The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol, 1993, 22, 6A-13A.
21. Holz GG: Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes, 2004, 53, 5-13.
22. Holz GG, Chepurny OG, Schwede F: Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors. Cell Signal, 2008, 20, 10-20.
23. Hothi SS, Gurung IS, Heathcote JC, Zhang Y, Booth SW, Skepper JN, Grace AA, Huang CLH: Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart. Pflugers Arch, 2008, 457, 253-270.
24. Hunter JJ, Chien KR: Signaling pathways for cardiac hypertrophy and failure. N Engl J Med, 1999, 341, 1276-1283.
25. Huston E, Lynch MJ, Mohamed A, Collins DM, Hill EV, MacLeod R, Krause E et al.: EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation. Proc Natl Acad Sci USA, 2008, 105, 12791-12796.
26. 2+ release and exocytosis in pancreatic beta-cells. J Biol Chem, 2003, 278, 8279-8285.
27. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE: A family of cAMP-binding proteins that directly activate Rap1. Science, 1998, 282, 2275-2279.
28. 2+ -controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors. J Biol Chem, 2004, 279, 46497-46508.
29. Kranias EG, Bers DM: Calcium and cardiomyopathies. Subcell Biochem, 2007, 45, 523-537.
30. Kwak HJ, Park KM, Choi HE, Chung KS, Lim HJ, Park HY: PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways. Cell Signal, 2008, 20, 803-814.
31. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med, 1990, 322, 1561-1566.
32. Li Y, Asuri S, Rebhun JF, Castro AF, Paranavitana NC, Quilliam LA: The RAP1 guanine nucleotide exchange factor Epac2 couples cyclic AMP and Ras signals at the plasma membrane. J Biol Chem, 2006, 281, 2506-2514.
33. Maillet M, Robert SJ, Cacquevel M, Gastineau M, Vivien D, Bertoglio J, Zugaza JL et al.: Crosstalk between Rap1 and Rac regulates secretion of sAPPalpha. Nat Cell Biol, 2003, 5, 633-639.
34. Margarit SM, Sondermann H, Hall BE, Nagar B, Hoelz A, Pirruccello M, Bar-Sagi D, Kuriyan J: Structural evidence for feedback activation by Ras. GTP of the Ras-specific nucleotide exchange factor SOS. Cell, 2003, 112, 685-695.
35. McConnachie G, Langeberg LK, Scott JD: AKAP signaling complexes: getting to the heart of the matter. Trends Mol Med, 2006, 12, 317-323.
36. Métrich M, Lucas A, Gastineau M, Samuel JL, Heymes C, Morel E, Lezoualc'h F: Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res, 2008, 102, 959-965.
37. Morel E, Marcantoni A, Gastineau M, Birkedal R, Rochais F, Garnier A, Lompré AM et al.: cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circ Res, 2005, 97, 1296-1304.
38. Movsesian MA, Bristow MR: Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy. Curr Top Dev Biol, 2005, 68, 25-48.
39. 2+ mobilization in cardiac myocytes. J Biol Chem, 2007, 282, 5488-5495.
40. 2+/calmodulin kinase signalling pathway in rat cardiac myocytes. J Physiol, 2007, 583, 685-694.
41. Ponsioen B, Zhao J, Riedl J, Zwartkruis F, van der Krogt G, Zaccolo M, Moolenaar WH et al.: Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep, 2004, 5, 1176-1180.
42. Poppe H, Rybalkin SD, Rehmann H, Hinds TR, Tang XB, Christensen AE, Schwede F et al.: Cyclic nucleotide analogs as probes of signaling pathways. Nat Methods, 2008, 5, 277-278.
43. Qiao J, Mei FC, Popov VL, Vergara LA, Cheng X: Cell cycle-dependent subcellular localization of exchange factor directly activated by cAMP. J Biol Chem, 2002, 277, 26581-26586.
44. Rangarajan S, Enserink JM, Kuiperij HB, de Rooij J, Price LS, Schwede F, Bos JL: Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor. J Cell Biol, 2003, 160, 487-493.
45. Raymond DR, Wilson LS, Carter RL, Maurice DH: Numerous distinct PKA-, or EPAC-based, signalling complexes allow selective phosphodiesterase 3 and phosphodiesterase 4 coordination of cell adhesion. Cell Signal, 2007, 19, 2507-2518.
46. Rehmann H, Arias-Palomo E, Hadders MA, Schwede F, Llorca O, Bos JL: Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B. Nature, 2008, 455, 124-127.
47. Rehmann H, Das J, Knipscheer P, Wittinghofer A, Bos JL: Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state. Nature, 2006, 439, 625-628.
48. Rehmann H, Rueppel A, Bos JL, Wittinghofer A: Communication between the regulatory and the catalytic region of the cAMP-responsive guanine nucleotide exchange factor Epac. J Biol Chem, 2003, 278, 23508-23514.
49. Robert S, Maillet M, Morel E, Launay JM, Fischmeister R, Mercken L, Lezoualc'h F: Regulation of the amyloid precursor protein ectodomain shedding by the 5-HT4 receptor and Epac. FEBS Lett, 2005, 579, 1136-1142.
50. Roscioni SS, Elzinga CR, Schmidt M: Epac: effectors and biological functions. Naunyn Schmiedebergs Arch Pharmacol, 2008, 377, 345-357.
51. Schaub MC, Hefti MA, Zaugg M: Integration of calcium with the signaling network in cardiac myocytes. J Mol Cell Cardiol, 2006, 41, 183-214.
52. Schmidt M, Evellin S, Weernink PA, von Dorp F, Rehmann H, Lomasney JW, Jakobs KH: A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat Cell Biol, 2001, 3, 1020-1024.
53. Schmidt M, Sand C, Jakobs KH, Michel MC, Weernink PA: Epac and the cardiovascular system. Curr Opin Pharmacol, 2007, 7, 193-200.
54. Sokołowska P, Nowak JZ: Constitutive activity of beta-adrenergic receptors in C6 glioma cells. Pharmacol Rep, 2005, 57, 659-663.
55. Somekawa S, Fukuhara S, Nakaoka Y, Fujita H, Saito Y, Mochizuki N: Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res, 2005, 97, 655-662.
56. Ulucan C, Wang X, Baljinnyam E, Bai Y, Okumura S, Sato M, Minamisawa S et al.: Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. Am J Physiol Heart Circ Physiol, 2007, 293, H1662-672.
57. Wang Z, Dillon TJ, Pokala V, Mishra S, Labudda K, Hunter B, Stork PJ: Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation. Mol Cell Biol, 2006, 26, 2130-2145.
58. 2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest, 2006, 116, 675-682.
59. Yokoyama U, Patel HH, Lai NC, Aroonsakool N, Roth DM, Insel PA: The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals. Proc Natl Acad Sci USA, 2008, 105, 6386-6391.